Results 21 to 30 of about 3,933 (187)
Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid
Orphanet Journal of Rare Diseases, 2018 Background Mucous membrane pemphigoid is a group of chronic subepithelial autoimmune blistering diseases that mainly affect mucous membranes. Laminin 332-specific autoantibodies are present in approximately 1/3 of the patients, being associated with an ...
Roxana Chiorean +9 more
doaj +2 more sources
The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature [PDF]
Journal of Research in Medical Sciences, 2016 Background: Mucous membrane pemphigoid (MMP) is considered an autoimmune blistering disease that predominantly affects mucous membranes. Various treatments are available for controlling the diseases, but not all of them may respond. Materials and Methods:
Soheil Tavakolpour
doaj +2 more sources
Mucous Membrane Pemphigoid [PDF]
, 2021 This chapter is focused on mucous membrane pemphigoid (MMP), a group of acquired subepidermal auto-immune blistering diseases that predominantly affect the mucous membranes. MMP is caused by autoantibodies directed against structural proteins of the dermal-epidermal junction including BP180, BP230, type VII collagen, and laminin 332.
Lamberts, Aniek +2 more
openaire +2 more sources
Real-Time Experience of Abrocitinib for the Treatment of Mucous Membrane Pemphigoid: A Case Report [PDF]
Patient Preference and AdherenceYan Teng, Mingyang Ren, Xianhong Yang, Wei Lu, Xiaohua Tao Center for Plastic & Reconstructive Surgery, Department of Dermatology, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital of Hangzhou Medical College, Hangzhou, 310014, People’s
Teng Y, Ren M, Yang X, Lu W, Tao X
doaj +2 more sources
Mucous Membrane Pemphigoid After Anti-PD-1 Therapy: Risk-Stratified Management and Treatment Outcomes. [PDF]
Int J DermatolABSTRACT Mucous membrane pemphigoid (MMP) following anti‐programmed cell death‐1 (PD‐1) therapy is rare but increasingly reported. Management of high‐ and low‐risk MMP in this setting and the potential oncologic trade‐offs remain poorly defined. We performed a narrative synthesis of all published cases of anti‐PD‐1‐associated MMP, following MEDLINE ...
Dienes S, Esfandiari N, Daveluy S.
europepmc +2 more sources
Case Reports in Dermatology, 2022 Bullous pemphigoid is the most common acquired bullous disease with an autoimmune basis and a tendency to involve mostly old people. By rising incidence of diabetes all over the world, consumption of antidiabetes medications has also increased.
Kamran Balighi +4 more
doaj +1 more source
European Journal of Case Reports in Internal Medicine, 2022 Bullous pemphigoid is a rare autoimmune dermatologic disease that usually occurs in the elderly. Mucous membrane lesions occur in about 10–35% of patients and are almost always limited to the oral mucous membrane.
Catarina Castelo Branco +2 more
doaj +1 more source
Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology [PDF]
Anais Brasileiros de Dermatologia, 2019 : Bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita are subepidermal autoimmune blistering diseases whose antigenic target is located at the basement membrane zone.
Claudia Giuli Santi +6 more
doaj +1 more source
Clinical periodontal diagnosis
Periodontology 2000, EarlyView., 2023 Abstract Periodontal diseases include pathological conditions elicited by the presence of bacterial biofilms leading to a host response. In the diagnostic process, clinical signs such as bleeding on probing, development of periodontal pockets and gingival recessions, furcation involvement and presence of radiographic bone loss should be assessed prior ...
Giovanni E. Salvi +5 more
wiley +1 more source